Roundup: News sparks market mayhem, gamers hate Spore DRM, DoJ eyes Google antitrust case, and more
With both DEMO and TechCrunch 50 going on, there’s almost too much to report. Here are some of the extra bits:
Old news becomes new problem — A six year old article about a United Airlines bankruptcy filing re-appeared on Google News Monday morning, triggering a massive sell-off of the company’s stock and deftly illustrating the potential dangers of modern (dis)information dissemination.
Spore spawns DRM hatred — The much-anticipated game Spore (see our interview with creator Will Wright) has… Continue Reading
Gene expression diagnostic company XDx raises $35.4M more
XDx, the startup behind a test measuring gene activity in the blood, is raising an additional $35.4 million in its fifth round of funding, according to VentureWire.
The Brisbane, Calif. company filed for an IPO of up to $86.3 million back in October, but has reportedly made a filing with the Securities and Exchange Commission saying it’s raising a fifth round of up to $61 million. It’s not clear who the new backers are.
The company received… Continue Reading
XDx marks a spot: An $86M IPO for gene-expression diagnostics
(UPDATED: See below.)
When XDx yesterday filed to raise up to $86.3 million in an IPO, the Brisbane, Calif., company joined just a handful of similar molecular-diagnostic companies to test the public markets. XDx specializes in a new type of diagnostic test that measures gene activity — technically, “gene expression” — in blood.
Gene-expression diagnostics have only been around for a few years, and they’re been slow to catch on. The tests use “gene chips” that measure the… Continue Reading
XDx looking to raise $25 million more for personalized medicine
XDx, a Brisbane, Calif. company that monitors the immune system with personalized medicine based on insights from the Human Genome Project, said it is raising up to $25 million more in cash.
The news, reported this morning by VentureWire (sub required) would be the company’s fifth round of venture capital. The company has already raised a total of $100.5 million since being founded in 2000. The fact that such a mature company, with well-known backers, is… Continue Reading